Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results from the CorEvitas Rheumatoid Arthritis Registry

CONCLUSION: Tofacitinib effectiveness (CDAI LDA) was observed in a US real-world setting of patients with RA regardless of tofacitinib regimen, line of therapy, time of initiation, and dose. (ClinicalTrials.gov: NCT04721808).PMID:38359941 | DOI:10.3899/jrheum.2023-0752

Source: Journal of Rheumatology - February 15, 2024 Category: Rheumatology Authors: Dimitrios A Pappas Jacqueline O'Brien Page C Moore Rhiannon Dodge Rebecca Germino Karim R Masri Clifton O Bingham Laura C Cappelli Source Type: research